18
Feb
La medicina del futuro è bio e “su misura”
La medicina del futuro è bio e “su misura”....
At the core of
Advanced Therapies
Advanced Therapies
At the core of
About Anemocyte
Anemocyte is a BMO, a lead innovator in the field of Advanced Therapies. A dynamic reality, driving force behind projects aiming to truly improve the quality of our lives. A solid organization, thanks to its strong scientific, technical, regulatory expertise, moved by a deep passion for life, today Anemocyte is the place where the Therapies of tomorrow are born.
Anemocyte does not stand alone in its pursuit, as it is part of the Nine Trees Group. Over sixty years of experience, serving the pharmaceutical industry worldwide. Nine Trees Group is an international reality able to combine with passion transversal competences in chemistry and biology, in accordance with the highest international quality standards.
the Infinite Alpha 
The naming of Anemocyte is the result of the combination of the words “ánemos” and “cyte”. From this union, the Infinite Alpha is created, a symbol that incorporates the values of the company.
Want to know more? Watch the video
OUR MISSION
To be the core
of Cell &
Gene Therapy
In a constantly evolving environment like the medical
and bio-pharmaceutical field, the new frontier is represented
by Advanced Therapies.
Anemocyte dedicates its knowledge and its talents to anticipate and transform this potential into tangible solutions. Anemocyte is at the heart of change, where a challenge becomes a result, and a limit becomes an opportunity. What drives our talents is the love for innovation, the commitment and dedication to constantly improve the quality of the patients’ lives. Our talents are here to restore life, creating a new future.
OUR VISION
Talented Souls
Innovating Life
Anemocyte looks at the present, anticipating the future.
A future where medicine will be closer to the people and of the people. A future where each individual’s participation can make a crucial and vital difference. Anemocyte aims to become the link between the scientific community and our society, a place where science and soul meet.
Our People
Anemocyte
means talents
At the center of evolution, there are people who believe that change is possible. Here at Anemocyte, we support, value and inspire those with a vision of a different world. A world where science can give life new opportunities. Those who made our mission and vision theirs, find in Anemocyte the perfect environment to develop their abilities. When we find a new talent, we discover potential growth for our company project. Personal skills and the ability to dream go hand in hand with professional and business growth. What we make, is possible only thanks to our talents.
I HAVE A TALENTED SOUL FOR…
DO YOU THINK YOU HAVE WHAT IT TAKES TO BE PART OF ANEMOCYTE?
Check for our open positions
or
Apply to the Anemocyte Continuous Recruitment Process: we are always looking for interesting candidates with talented souls!
Become an ANEMOCYTER!
Site Manager
& BUSINESS DEVELOPMENT
Supply Chain Manager
Development Manager
Supply Chain Manager
Supply Chain Assistant
Supply Chain Assistant
Person
Manager
Analytical Dev. Manager
Assistant
Analyst
Analyst
Manager
Specialist
Specialist
Specialist
Specialist
Manager
Scientist
Scientist
Scientist
Technician
WHERE WE ARE
Anemocyte Headquarters
- Strategic Position – Greater Milan Area, three international airports within 50 Km.
- GMP Facility – 500 sq. m. for Advanced Theraphy production under cGMP.
- Plasmid Manufacturing – 300m2 of cleanrooms, the plasmid unit of Anemocyte address manufacturing needs Plasmids for Viral Vectors from R&D to GMP.
TODAY
Advanced Therapy
Medicinal Products
We provide quality driven innovative
solutions for advanced therapies.
Cell and non-viral Gene Modified Cell platform
Manufacturing of autologous and allogeneic products.
Grade: GMP or High Quality
DNA Platform
Plasmid DNA for vaccination or viral vector production.
Grade: GMP or High Quality
Gene Therapy Platform
Process Development and implementation for viral vector and gene modified cells in our I&D unit.
Grade: High Quality
Plasmids
Anemocyte is the leading Italian producer of gene therapy plasmids and is one of the first of its kind in Europe. Having recently built a brand new Plasmid Manufacturing Unit – which is dedicated to producing plasmids for viral vectors – Anemocyte is equipped with state-of-the-art laboratories and facilities, having tripled its production output since 2018.
TOMORROW
Beyond the present,
creating a new future
Expansion phase 2018-2020
Cell Therapy Platform
Implementation of GMP spaces dedicated to Viral Vectors and Gene Modified cells production for clinical applications.
Grade: GMP or High Quality
Custom GMP Spaces
Custom GMP spaces to address up to commercial needs.
Scale: up to Commercial.
Meet us here
The XXI Scientific Convention
Riva del Garda (TN), IT
March 13-15, 2023
Meeting on the MED
Barcelona, SPAIN
April 12-14, 2023
ASGCT
Los Angeles, USA
May 16-20, 2023
ISCT
Paris
Paris, FR
May 31 - June 03, 2023
About us
Anemocyte news
- 18Feb
Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Phacilitate Leaders World 2020 in Miami
Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Phacilitate Leaders World...
PRESS AREA
In this press release page you can find a selection of the main articles about Anemocyte
published by newspapers and magazines, both online and on paper.
CONTACT US
Let’s make real change happen together.
Anemocyte S.r.l.
Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 | 21040 Gerenzano (VA) Italy
Ph: +39 02 99372311 | Fax: +39 02 99372313
VAT number: 12914940155
Share capital € 530.000,00 fully paid
R.E.A. 276961
Anemocyte is a proud member of
Anemocyte S.r.l.
Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 | 21040 Gerenzano (VA) Italy
Ph: +39 02 96474804 | Fax: +39 02 96474800
VAT number: 12914940155
Share capital € 530.000,00 fully paid
R.E.A. 276961